Evercore ISI Group analyst Robert Ottenstein maintains Monster Beverage (NASDAQ:MNST) with a Outperform and raises the price target from $105 to $115.
Biocept Q3 EPS $(0.33) Down From $(0.04) YoY, Sales $5.59M Down From $17.47M YoY
Biocept (NASDAQ:BIOC) reported quarterly losses of $(0.33) per share. This is a 725 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $5.59 million in sales this
